Loading data for CAH — first visit, this takes a few seconds.

Cardinal Health, Inc. (CAH)

NYSE: CAH · Real-Time Price · USD

239.35

+4.73 (2.02%)

At close: Sep 01, 2026, 8:00 PM

Alert

The price, the headline numbers and the latest news, in one place.

No data available

Bid	0
Market Cap	55.7B
Revenue (ttm)	254B
Net Income (ttm)	1.71B
	0.52
	7.37
	32.48
	17
P/B (ttm)	-19.34
P/S (ttm)	0.22
Earnings Date	Nov 5, 2026

Ask	0
Volume	1,299,814
Avg. Volume (20D)	2,178,747
Open	236.85
Previous Close	234.62
Day's Range	236.03 - 240.75
52-Week Range	145.87 - 258.30
Analyst	n/a
Price Target	n/a
Dividends	$2.06 (0.88%)
Ex-Dividend Date	Oct 1, 2026

About CAH

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generi...

[Read more]

Industry Medical Distribution

Sector Healthcare

IPO Date Aug 4, 1983

Employees 58,788

Stock Exchange NYSE

Ticker Symbol CAH

Website https://www.cardinalhealth.com

Full Company Profile

Financial Performance

In 2025, Cardinal Health's revenue was 222.58B, a decrease of -1.87% compared to the previous year's 226.83B. Earnings were 1.56B, an increase of 83.22%.

Financial Statements

Earnings Surprise

Cardinal Health has released their quarterly earnings on Aug 11, 2026:

Revenue of $60.94B misses estimates by $0, with 11.05% YoY growth.
EPS of 2.6 exceeds estimates by 0.18, with 25.00% YoY growth.

Next Earnings Release

Cardinal Health, Inc. is scheduled to release its earnings on Nov 5, 2026, before market opens.
Analysts project revenue of ... Upgrade

Why Price Moved

News

3 days ago · Motley Fool

AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio.

3 days ago · Motley Fool

Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.

5 days ago · Zacks

How CVS' Pharmacy & Consumer Wellness Is Positioned for H2 2026

CVS Health carries strong pharmacy momentum into H2 2026, with rising prescription volume, Rite Aid gains and higher profit.

1 week ago · Simply Wall St.

What Cardinal Health (CAH)'s New US$5 Billion Buyback and Q4 Results Mean For Shareholders

In August 2026, Cardinal Health reported fourth‑quarter sales of US$63,672 million and net income of US$398 million, alongside a new US$4.00 billion revolving credit facility, a fresh US$5.00 billion ...

1 week ago · StockStory

2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my...

Page 1 of 2

Cardinal Health, Inc. (CAH)